date:Jul 05, 2012
iotics for 15 years and has 45 published reviewed clinical trials.
Paradoxically, the science is getting stronger and consumers are aware the evidence is too strong,said Hersch.We continue to invest and there are studies going on as we speak. They absolutely have a future.
DuPont's Darribeau thought it was too early to tell what influence further delays from EFSA would have but said the industry was working to provide EFSA's requirements to grant probiotics health claims on digestive health an